ArticleOncotarget2016

Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models.

Michael S Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.